SCHEMBL30802436

SCHEMBL30802436

CCOC(=O)c1ccc2c(c1)nc(Cl)c1cc(C(=O)OCC)[nH]c12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 1/20 0.50
CCNB1 P14635 1/20 0.50
SIRT2 Q8IXJ6 2/20 0.47
SIRT1 Q96EB6 1/20 0.47
SIRT3 Q9NTG7 1/20 0.47
ALDH1A1 P00352 8/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
ALOX15 P16050 1/20 0.46
HRH3 Q9Y5N1 1/20 0.45
KDM4E B2RXH2 5/20 0.45
HPGD P15428 4/20 0.45
HSD17B10 Q99714 3/20 0.45
MMP2 P08253 1/20 0.44
MMP13 P45452 1/20 0.44
HCRTR1 O43613 2/20 0.44
MAPT P10636 3/20 0.44
TP53 P04637 1/20 0.44
RAB9A P51151 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
MEN1 O00255 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30885770 0.84 ALDH1A1 (0.48) SIRT2SIRT1SIRT3ALDH1A1L3MBTL1
SCHEMBL30779339 0.84 MMP13 (0.47) CDK1CCNB1ALDH1A1L3MBTL1ALOX15
SCHEMBL27088124 0.81 MMP13 (0.47) CDK1CCNB1ALDH1A1L3MBTL1ALOX15
SCHEMBL31095354 0.80 ALDH1A1 (0.53) SIRT2SIRT1SIRT3ALDH1A1L3MBTL1
SCHEMBL20588653 0.80 ALDH1A1 (0.53) SIRT2SIRT1SIRT3ALDH1A1L3MBTL1
SCHEMBL30802529 0.77 KDM4E (0.48) ALDH1A1KDM4EHPGDHSD17B10MEN1
SCHEMBL1458735 0.76 ALDH1A1 (0.58) SIRT2SIRT1SIRT3ALDH1A1L3MBTL1
SCHEMBL31472839 0.76 ALDH1A1 (0.50) SIRT2SIRT1SIRT3ALDH1A1L3MBTL1
SCHEMBL30724459 0.76 ALDH1A1 (0.45) SIRT2SIRT1SIRT3ALDH1A1L3MBTL1
SCHEMBL18706180 0.75 ALDH1A1 (0.53) SIRT2SIRT1SIRT3ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11970496-B1 Pyrrolo[3,2-c]quinoline compounds as CK2 inhibitors King Faisal University (SA) 2024-04-30 US disclosed
US-11958851-B1 Pyrrolo[3,2-c]quinoline compounds as CK2 inhibitors King Faisal University (SA) 2024-04-16 US disclosed
US-11945818-B1 Pyrrolo[3,2-c]quinoline compounds as CK2 inhibitors King Faisal University (SA) 2024-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11970496-B1 Pyrrolo[3,2-c]quinoline compounds as CK2 inhibitors CSNK2A3, CSNK2A1, CSNK1G2 CDK1 20/4885CCNB1 228/4885SIRT2 2668/4885
US-11945818-B1 Pyrrolo[3,2-c]quinoline compounds as CK2 inhibitors CSNK2A3, CSNK2A1, CSNK2A2 CDK1 19/4885CCNB1 260/4885SIRT2 2019/4885
US-11958851-B1 Pyrrolo[3,2-c]quinoline compounds as CK2 inhibitors SKP2, CSNK2A3, CKS2 CDK1 20/4885CCNB1 319/4885SIRT2 2064/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.